An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online asked about dosing two experimental peptides, BPC-157 and TB-500. They said they have a 20 mg vial of each, want to take 200 micrograms of each twice a day (so 400 µg total per day of each peptide), and wondered if that’s enough for “repair” because they’ve seen other posts saying 250 µg is a minimum. They also asked whether injecting (pinning) every day would be a problem, and mentioned money is tight so they want it to last longer. BPC-157 and TB-500 are not weight-loss drugs like Ozempic. They’re short chains of amino acids (peptides) that some people and labs study because they seem to help tissue healing in animals. BPC-157 is based on a protein found in the stomach and is sold as a research peptide; TB-500 is a portion of a natural protein called thymosin beta-4. Neither is an approved prescription medication for humans in most places. That means what you find online is often anecdote, small informal trials, or animal studies, not large, rigorous human clinical trials. What the available reports actually show is mixed and limited. Most of the controlled science is in animals (rats, mice) where certain doses and schedules sometimes sped up healing of tendons, ligaments, or gut injuries. Human evidence is mainly a mix of tiny uncontrolled reports, forum posts, and lab research. There isn’t a universally accepted “minimum effective dose” for people. Some users online report benefits at 200–250 µg daily; others use higher or split doses. Because these are self-reports, they can’t prove safety or effectiveness. Also dosing depends on many things—what’s being treated, body size, formulation—and none of that is standardized for humans. Why this matters: people with injuries or chronic pain sometimes look to these peptides because they hope for faster recovery than conventional treatment provides. If someone is considering them, knowing the weak evidence helps set realistic expectations: you might see anecdotal improvement, but it’s not guaranteed and is not backed by large clinical trials. Cost is a real concern, so some try lower or less frequent dosing to stretch a vial. That can reduce potential benefit, but it might be a reasonable harm-reduction approach if someone has decided to proceed despite the risks. Important caveats and risks: these peptides are largely unregulated when sold online. Dosing recommendations on forums are not medical advice. Injection carries infection risk if done improperly. Side effects are not well catalogued—some report local irritation, headaches, or no issues, but unknown long-term effects exist. People with allergies, pregnant or breastfeeding women, or those on other medications should be especially cautious. Because they aren’t approved drugs, you can’t rely on consistent purity or correct labeling from suppliers. If you’re thinking about trying these, the safest steps are to talk to a healthcare professional, consider approved treatments first, and if you proceed, use sterile technique and a reliable source—while recognizing that even then the science is uncertain. Bottom line: BPC-157 and TB-500 are experimental with limited human data; 200 µg twice daily is within the range some people use but isn’t proven optimal, and daily injections and unregulated sourcing carry real risks.
Source: r/Peptides